IRISanRaf

MUSELLA, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.333
AS - Asia 466
EU - Europa 153
Continente sconosciuto - Info sul continente non disponibili 30
AF - Africa 15
SA - Sud America 4
Totale 2.001
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.105
TR - Turchia 401
CA - Canada 228
IT - Italia 98
CN - Cina 53
EU - Europa 28
SC - Seychelles 13
DE - Germania 12
IE - Irlanda 11
SE - Svezia 6
CH - Svizzera 4
RU - Federazione Russa 4
FI - Finlandia 3
IN - India 3
NL - Olanda 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EG - Egitto 2
ES - Italia 2
GB - Regno Unito 2
HK - Hong Kong 2
IR - Iran 2
JP - Giappone 2
AT - Austria 1
BG - Bulgaria 1
BO - Bolivia 1
BR - Brasile 1
CL - Cile 1
EC - Ecuador 1
FR - Francia 1
HU - Ungheria 1
IQ - Iraq 1
KW - Kuwait 1
SG - Singapore 1
UA - Ucraina 1
Totale 2.001
Salva come PNG Salva come JPEG
Città #
San Mateo 448
Kocaeli 401
Toronto 225
Wilmington 113
Houston 83
Lawrence 78
Princeton 78
Chandler 54
Beijing 52
Ashburn 37
Rome 26
Los Angeles 24
Fairfield 18
Seattle 17
Woodbridge 16
West Jordan 10
Falls Church 9
Cambridge 8
Viggiù 5
Palermo 4
Redwood City 4
Bern 3
Florence 3
Helsinki 3
Kemerovo 3
Lariano 3
Pune 3
Al Qahirah al Jadidah 2
Alessandria 2
Andover 2
Berlin 2
Boardman 2
Città di Castello 2
Dublin 2
Las Vegas 2
Milan 2
Pistoia 2
Salt Lake City 2
Washington 2
Abano Terme 1
Amsterdam 1
Basra 1
Brampton 1
Brooklyn 1
Budapest 1
Cagliari 1
Charlotte 1
Dallas 1
Des Moines 1
Easley 1
Fremont 1
Geislingen an der Steige 1
Glasgow 1
Kharkov 1
Kuwait City 1
Montréal 1
Naples 1
New York 1
Norwalk 1
Padova 1
Philadelphia 1
Piacenza 1
Quito 1
Redmond 1
Rockville 1
Sindelfingen 1
Sofia 1
Stockholm 1
Sucre 1
São Paulo 1
Tokyo 1
Veroli 1
Vienna 1
Waterford 1
Zagarolo 1
Zurich 1
Totale 1.789
Salva come PNG Salva come JPEG
Nome #
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 48
4-Aminopyridine derivatives with anticholinesterase and antiamnesic activity 48
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 42
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 41
Linking synaptopathy and gray matter damage in multiple sclerosis 40
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 40
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 39
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 39
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis 38
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 37
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis. 36
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 36
TNF-α-mediated anxiety in a mouse model of multiple sclerosis 35
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 34
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 33
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 32
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 32
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 31
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects 31
Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli 30
Obesity worsens central inflammation and disability in multiple sclerosis 30
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 30
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 30
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum 30
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis 29
Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis 29
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 29
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 29
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 29
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 29
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 29
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 28
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 28
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 27
Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis 27
TRPV1 channels facilitate glutamate transmission in the striatum 27
MiR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation 27
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 26
Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum 26
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 26
Before or after does it matter? Different protocols of environmental enrichment differently influence motor, synaptic and structural deficits of cerebellar origin 26
Adaptations of striatal endocannabinoid system during stress 26
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 26
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis 25
Cerebellar control of cortico-striatal LTD 25
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum 24
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 24
Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmission 24
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 24
Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study 23
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 23
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 23
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 23
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 23
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 22
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 22
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis 22
Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage 22
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 22
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 22
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 22
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 22
Interleukin-1β causes anxiety by interacting with the endocannabinoid system 21
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis 21
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 21
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 21
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 21
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis 20
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 20
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors 20
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 20
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 20
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 19
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 12
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 11
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 11
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 11
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 9
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 9
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 8
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 7
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 3
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 3
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 3
Electrophysiology of Endocannabinoid Signaling 3
Preventive exercise and physical rehabilitation promote long‐term potentiation‐like plasticity expression in patients with multiple sclerosis 3
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 2
Totale 2.141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.971
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020124 0 7 1 1 21 0 0 3 2 10 43 36
2020/2021650 48 34 5 1 27 25 33 9 16 13 403 36
2021/2022871 2 222 232 4 6 8 34 92 20 226 19 6
2022/2023306 179 4 4 19 8 14 0 9 10 19 23 17
2023/2024129 4 6 8 41 6 14 1 12 0 37 0 0
Totale 2.141